Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Overall Study	STARTED	Control Placebo	18
Overall Study	STARTED	Control Alfuzosin	20
Overall Study	STARTED	Constipation Placebo	18
Overall Study	STARTED	Constipation Alfuzosin	18
Overall Study	COMPLETED	Control Placebo	17
Overall Study	COMPLETED	Control Alfuzosin	19
Overall Study	COMPLETED	Constipation Placebo	15
Overall Study	COMPLETED	Constipation Alfuzosin	16
Overall Study	NOT COMPLETED	Control Placebo	1
Overall Study	NOT COMPLETED	Control Alfuzosin	1
Overall Study	NOT COMPLETED	Constipation Placebo	3
Overall Study	NOT COMPLETED	Constipation Alfuzosin	2

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01834729/flow